AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 63 filers reported holding AURINIA PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 4.38 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $1,230,000 | +1821.9% | 60,695 | +410.3% | 0.06% | +1933.3% |
| Q3 2019 | $64,000 | -47.1% | 11,895 | -35.3% | 0.00% | -57.1% |
| Q2 2019 | $121,000 | +45.8% | 18,395 | +44.9% | 0.01% | +40.0% |
| Q1 2019 | $83,000 | -73.4% | 12,695 | -77.2% | 0.01% | -61.5% |
| Q2 2018 | $312,000 | +4.0% | 55,595 | -16.2% | 0.01% | 0.0% |
| Q4 2017 | $300,000 | -49.8% | 66,365 | -32.0% | 0.01% | -59.4% |
| Q2 2017 | $598,000 | +106.9% | 97,600 | +147.7% | 0.03% | +146.2% |
| Q1 2017 | $289,000 | – | 39,400 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Berry Street Capital Management LLP | 1,987,500 | $24,605,000 | 2.79% |
| NEA Management Company, LLC | 3,969,834 | $49,146,000 | 1.42% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 133,117 | $1,648,000 | 0.90% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 435,000 | $3,955,000 | 0.89% |
| ACT CAPITAL MANAGEMENT, LLC | 67,500 | $836,000 | 0.88% |
| Artal Group S.A. | 1,000,000 | $12,380,000 | 0.52% |
| CTC Capital Management, LLC | 12,800 | $158,000 | 0.42% |
| KESTRA PRIVATE WEALTH SERVICES, LLC | 581,910 | $7,204,000 | 0.36% |
| Affinity Asset Advisors, LLC | 175,000 | $2,167,000 | 0.35% |
| Bellevue Group AG | 2,405,825 | $29,784,000 | 0.35% |